Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Kadmon Holdings, Inc.

TRADE

NYSE: KDMNHealthcare / Biotechnology / USA
2.61-0.13-4.74%Vol 705 3911Y Perf -25.85%
Oct 19th, 2018 16:02
BID0.00 ASK0.00
Open2.74 Previous Close2.74
Pre-Market- After-Trading2.61
 - -%  - -%
Target Price
15.50 
Analyst Rating
Strong Buy 1.00
Potencial %
493.87 
Finscreener Ranking
★★★★     54.62
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★★+     48.31
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★     43.84
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)295 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
0.31 
Earnings Date
8th Nov 2018

Today's Price Range

2.602.77

 

52wk Range

2.605.86

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-22.09%
3 Months
-22.78%
6 Months
-37.71%
1 Year
-25.85%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
KDMN2.61-0.1300-4.74
AAPL219.313.29001.52
GOOG1 096.468.49000.78
MSFT108.660.16000.15
XOM81.970.12000.15
WFC52.89-0.2100-0.40
JNJ139.05-0.4500-0.32
FB154.05-0.8700-0.56
GE12.560.18001.45
JPM107.91-0.1800-0.17
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.00
Current Ratio 3.10
Long Term Debt to Total Capital -
Total Debt to Equity 0.29
Interest Coverage -5.90
Leverage Ratio 3.80
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin56.80
EBIT Margin-752.10
EBITDA Margin-716.90
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio 2.20
PB Ratio 3.19
PS Ratios 137.37
Price to Cash Flow -
Price to Free Cash Flow -5.70
Cash Flow Per Share -0.92
Price to Tangible Book3.31
Book Value per Share0.86
Enterprise Value (in ths.)248 807
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -444.07
Return on Assets (5Y Avg) -
ROA last 12 Months -34.65
Return on Capital (5Y Avg) -
ROC last 12 Months -87.81
Return on invested Capital Q 35.21
Return on invested Capital Y-
Assets Turnover0.00
Receivables Turnover2.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)2 256
Revenue per Share 0.02
Revenue Growth 3 Years -55.01
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.26-0.2119.23
Q01 2018-0.25-0.27-8.00
Q04 2017-0.34-0.2429.41
Q03 2017-0.41-0.42-2.44
Q02 2017-0.55-0.4420.00
Q01 2017-0.50-0.3922.00
Q04 2016-0.52-0.503.85
Q03 2016-0.79-4.23-435.44
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.224.35Positive
12/2018 QR-0.23-4.55Negative
12/2018 FY-0.942.08Positive
12/2019 FY-0.5446.00Positive
Next Report Date8th Nov 2018
Estimated EPS Next Report-0.22
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume705 391
Shares Outstanding (in ths.)113 100
Trades Count2 418
Dollar Volume1 816 543
Avg. Volume817 640
Avg. Weekly Volume798 537
Avg. Monthly Volume720 519
Avg. Quarterly Volume735 563

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

38%62%

Bearish Bullish

29%71%

Bearish Bullish

38%62%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (75.00 %)
4 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
1 (25.00 %)
1 (20.00 %)
RatingStrong Buy
1.00
Moderate Buy
2.00
Moderate Buy
1.80

There are no comments yet.

News

x